M&S Technologies’ Clinical Trial Suite (CTS) Version 2 Provides Sponsor Control with Customized Protocols

Share Article

CTS is a fully automated, customizable suite of software modules designed specifically for use in vision-related Research and Clinical Trials.

News Image
CTS delivers the precise information that Pharmaceutical companies require to assess the viability of their new products.

M&S Technologies, Inc., the first name in computerized vision testing systems, releases Version 2 of Clinical Trial Suite (CTS). This new version allows pharmaceutical companies to gain greater information and control in trials with customized testing protocols designed specifically for them.

CTS consists of a variety of visual acuity and contrast sensitivity algorithms that easily step the user through the eye charts presented and directly respond to user input regarding correct/incorrect results. Each suite can be customized specifically to meet the sponsors’ trial needs. Numerous pharmaceutical trial sponsors have successfully engaged the customization aspect, where the protocol is designed to quickly identify patterns in the patient data, thereby leading to a dramatic improvement in the sponsors’ ability to identify and assess the results delivered by their new products.

The CTS modules adhere to the ANSI and ISO standards, are accepted for use in Phase III Endpoint Trials and are peer-reviewed and published by prominent industry professionals. The science behind CTS ensures a high level of precision and repeatability from site to site and visit to visit for reliable results.

More details about CTS can be viewed online HERE. or watch a brief video HERE.

“Pharmaceutical companies have recognized the significant time-savings of CTS at study sites and the ability of our Suite to provide unbiased, computer generated data for easy collection and dissemination. As sponsors have grown confident and comfortable with the use of our computerized CTS products, they are taking the next step to customize CTS to deliver the precise information that they require to assess the viability of their new products. The importance of these customized protocols is the ability to provide marketers of vision care products a speed to market advantage that hasn’t been experienced with any previous clinical trial testing device.”
Joe Marino, President

About M&S Technologies:
Founded in 1990, M&S Technologies is a software company specializing in visual testing systems and dedicated to developing the very best products for eye-care professionals, optometry schools and universities, and products used in clinical trials. To date, over 26,000 systems are in use across 39 countries with a growing network that includes 25 distributors and several strategic industry alliances. Superior service, industry-leading technology and products that define the cutting edge have been the hallmarks of M&S for over 25 years.

For more information, please contact:
Karen Waller
M&S Technologies, Inc.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Carolyn Crabb
Follow >
M&S Technologies, Inc.
Like >
Visit website